|  | COVID-19 |  |  |
---|---|---|---|---|
Controls | All | Overweight | Obese | |
(n = 11) | (n = 50) | (n = 22) | (n = 28) | |
Age (years) | 53.7 (32–90) | 54.6 (31–85) | 54.6 (31–84) | 54.7 (31–85) |
Sex (female) | 4 | 18 | 5 | 13 |
Body mass (kg) | 76.6 (48–99) | 90 (59–135) A | 82 (59–100) | 96.4 (74–135) A,B |
BMI (all) | 26.6 (21.9–31.4) | 30.9 (24.2–46.1) A | 27.3 (25–29.8) | 33.8 (30.0–46.1) A,B |
 Females | 25.3 (21.9–29.1) | 31.7 (25.0–38.0) | 26.8 (25.2–29.1) | 33.6 (30.0–38.0) |
 Males | 27.3 (22.5–31.1) | 30.5 (24.2–46.1) | 27.4 (25–29.8) | 34.0 (30.1–46.1) |
Ethnicity (%) | Â | Â | Â | Â |
 White | 54.5 | 78 | 95.4 | 21.4 |
 Brown | 21.2 | 14 | 17.8 | |
 Black | 18.1 | 8 | 4.5 | 60.7 |
Length of in-hospital stay (days) | -- | 10.3 (3–46) | 9.4 (3–28) | 11 (3–46) |
Clinical score (WHO) | -- | 2.9 (1–8) | 2.9 (1–8) | 2.9 (1–7) |
Ghrelin (mg/dL) | 0.03 (0–0.10) | 0.018 (0–0.14) | 0.0069 (0–0.03) | 0.028 (0–0.14) |
Leptin (mg/dL) | 2053 (520.1–4204) | 3878 (1005–8973) | 3473 (1011–8662) | 4163 (1005–9973) A |
Adiponectin (mg/dL) | 2568 (2021–2996) | 2555 (2050–3153) | 2605 (2050–3153) | 2517 (2092–2930) |